en · de · es
analytical-notes.peptides5388.com › Faq › Sr9009 Background And Mechanism — Reference Sheet

Sr9009 Background And Mechanism — Reference Sheet

By Editorial Desk · published 2025-10-01 · last reviewed 2025-11-08 · Faq

This is a working overview of REV-ERB agonist, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2025-11-08. Anything still debated is marked as such rather than presented as settled.

SR9009 Background and Mechanism

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

Analytical Detection and Laboratory Handling

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Sr9009 at a glance

PropertyValueNotes
Chemical classSynthetic small-molecule REV-ERB agonistNot a hormone or natural product
Primary targetsREV-ERBα and REV-ERBβNuclear receptors involved in circadian and metabolic regulation
AppearanceWhite to off-white solidTypical for purified research samples
SolubilitySoluble in DMSO and ethanol; low water solubilityLaboratory solubility depends on solvent and purity
Common synonymsSR9009; StenabolicStenabolic is a colloquial name, not a formal chemical name

Background and Pharmacological Mechanism

Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.

SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.

Related pages on this site

Handling Storage and Quality Control

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

SR9009 Handling and Quality Control

Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.

SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.

SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.

Background from the literature

Valve canceled a port of Half-Life for MacOS, developed by Logicware, in 2000. Newell cited several shortcomings such as the lack of an auto-updater and the lack of Team Fortress Classic, and in general was worried that Mac players would be "second-class customers" due to Valve being unable to justify ongoing updates to the Mac port. Rebecca Heineman, the co-founder of Logicware, said that the main reason that Valve canceled the Mac port was that Apple had angered Valve by misrepresenting sales projections (by an order of magnitude). She said the port was complete and three weeks from release when it was canceled due to preorder numbers being much lower than Valve expected. Valve released ports for OS X and Linux in 2013. Captivation Digital Laboratories and Gearbox Software developed a port of Half-Life for the Dreamcast, with new character models and textures and an exclusive expansion, Blue Shift. Following the cancellations of several third-party games in the wake of Sega's decision to discontinue the Dreamcast in March 2001, Sierra cancelled the port weeks before its scheduled release in June, citing "changing marketing conditions". Blue Shift was ported to Windows. The Dreamcast port became the basis of the Half-Life port for PlayStation 2, released in late 2001. This version added competitive play and a co-op expansion, Half-Life: Decay. In 2004, Valve released Half-Life: Source, a version of Half-Life ported to their new game engine, Source. It adds ragdoll physics, advanced water effects, and 5.1 surround sound.

=== Syphilis === Cardiolipin from a cow heart is used as an antigen in the Wassermann test for syphilis. Anti-cardiolipin antibodies can also be increased in numerous other conditions, including systemic lupus erythematosus, malaria and tuberculosis, so this test is not specific.

Toronto City Council has announced its intention to challenge the bill on legal grounds. In July 2025, an Ontario court ruled that removing Toronto bike lanes was unconstitutional; the government will appeal the decision. In August 2026, the Ontario appeals court ruled that there is no constitutional obligation to regulate the use of roads in any particular manner, allowing Ford's government to remove Toronto bike lanes. In 2025, automated speed enforcement fell under controversy. The Kathleen Wynne Liberal government introduced legislation allowing automated speed enforcement in 2017, before the Ford government passed it in 2019. By October 2025, Ford announced legislation that would ban the use of speed cameras, calling them "cash grabs". The move came after many speed cameras in Toronto were vandalized. Over 20 mayors, including Olivia Chow of Toronto, spoke out against the proposed legislation, as well as municipalities, school boards, and police chiefs. On November 14, the Building a More Competitive Economy Act was passed, that struck the section of the Highway Traffic Act that permitted automated speed enforcement. Instead, the government launched a $210 million road safety initiatives fund for municipalities to implement traffic calming measures. His government has also reinstated the Northlander passenger train service and has broken ground on the East Harbour Transit Hub. Ford also expanded GO Transit services.

Oat β-glucans are water-soluble mixed-linkage β-glucans derived from the endosperm of oat kernels known for their dietary contribution as components of soluble fiber. Due to their property to lower serum total cholesterol and low-density lipoprotein cholesterol, and potentially reduce the risk of cardiovascular diseases, oat β-glucans have been assigned a qualified health claim by the European Food Safety Authority and the US Food and Drug Administration.

=== Later medieval works === The Fisher King is a character in Chrétien's Perceval (1180) which is the first of a series of stories and texts on the subject of Perceval and the Grail. In his work, Chrétien did not say how the quester was related to this Fisher King. In later romances it is made clear, in the end, that he is the uncle of the quester. According to Eugène Vinaver, Chretien's work features two Maimed Kings. Parzival was written in 1210 by Wolfram von Eschenbach, thirty years after Perceval. Although a different work, it is strikingly similar to Perceval. The story revolves around the Grail Quest and once again the main character is Perceval (as Parzival). As in Perceval, the story has its protagonist fail to ask the healing question, which results in him Questing for years. However, Parzival differs from Perceval in three major ways. Firstly, the Fisher King is no longer nameless and is called Anfortas. Secondly, Eschenbach thoroughly describes the nature of the wound; it is a punishment for wooing a woman who is not meant for him (every Grail keeper is to marry the woman the Grail determines for him), and it causes him immense pain. Lastly, Parzival comes back to cure the Fisher King. Parzival, unlike its predecessor Perceval, has a definitive ending. The quester is the son of Herzeloyde, who is the sister of Anfortas.

Sources: en.wikipedia.org

Reference notes

18 January The ONS reports that inflation dropped for the second month running, to 10.5% in December, from 10.7% the previous month. At the two extremes of the ONS's list of "notable movements" that contribute to the overall figure, 'clothing and footwear' price inflation dropped from 7.5% to 6.4%, 'furniture and household goods' dropped from 10.8% to 9.8%, 'food and non-alcoholic beverages' rose from 16.5% to 16.9%, and 'restaurants and hotels' rose from 10.2% to 11.4%. BBC News reports that Church of England bishops will not give their backing to a change in teaching that would allow them to marry same-sex couples, but the Church will offer "prayers of dedication, thanksgiving or God's blessing" to gay couples. 19 January – Prime Minister Rishi Sunak apologises for taking his seat belt off in a moving car to film a social media clip. Lancashire Police later say they are "looking into" the incident. He is issued with a fixed-penalty notice the following day. 20 January The Church of England issues an apology for the "shameful" times it has "rejected or excluded" LGBTQ+ people, while Archbishop of Canterbury Justin Welby says he supports the changes that allow blessings to be offered to gay couples, but says he will not personally use them because he has a "responsibility to the whole communion". The High Court awards £39m in damages against Frimley Health NHS Foundation Trust in Surrey to a girl whose limbs were amputated after she was wrongly diagnosed.

After the lipids are separated on the GC or LC column they are detected using mass spectrometry (MS). Mass spectrometry characterizes the mass of a given molecule by first fragmenting and ionizing the molecule into smaller carbocations known as daughter ions. Each molecule has a diagnostic fragmentation pattern in a given ion source. Classes of molecules often have a characteristic fragment ion that can be used to search for those molecules in a total ion current. This is known as a selected ion chromatogram (SIC). SICs are used in single quadrupole mass spectrometers. When two quadrupoles are attached in tandem mass spectrometry (MS/MS), two mass fragments can be isolated simultaneously. MS/MS experiments allow the total ion current to be filtered by both the molecular ion and the characteristic fragment ion of a given molecule. The molecular ion of gammacerane with an electron impact source is 412 m/z. Like other pentacyclic triterpenoids, it has a characteristic 191 m/z mass fragment. The combination of 412 m/z and 191 m/z is known as the 412-->191 m/z transition and can be used to search a chromatogram specifically for gammacerane.

Sternglass, a radiologist at the University of Pittsburgh, published several studies describing the effect of radiation from nuclear tests and the vicinity of nuclear power plants on infant mortality. In 1971, the UASEC reduced the maximum allowable radiation dose by a factor of 100. Subsequently, nuclear technology was based on the principle of "As Low As Reasonably Achievable" (ALARA). This was a coherent principle as long as it was assumed that there was no threshold and that all doses were additive. In the meantime, a transition to "As High As Reasonably Safe" (AHARS) is increasingly being discussed. For the question of evacuation after accidents, a transition to AHARS seems absolutely necessary. In both the Chernobyl and Fukushima cases, hasty, poorly organized and poorly communicated evacuations caused psychological and physical damage to those affected - including documented deaths in the case of Fukushima. By some estimates, this damage is greater than would have been expected had the evacuation not taken place. Voices such as Geraldine Thomas therefore question such evacuations in principle and call for a transition to shelter-in-place wherever possible.

Intracellular bacterial pathogens invade eukaryotic cells (which may lead to the formation of phagolysosomes and/or autophagy activation), or bacteria may be engulfed by phagocytes (macrophages, monocytes, neutrophils...). The bacteria-containing phagosome may then fuse with endosomes and lysosomes, leading to degradation of bacteria and generation of polymeric peptidoglycan fragments and muropeptides.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.

How does SR9009 work?

It binds REV-ERBα and REV-ERBβ and changes transcription of metabolic genes. This can affect circadian rhythm, lipid use, and mitochondrial function. The full downstream effects are still under study.

Is SR9009 proven to improve human performance?

No. Some rodent studies show increased endurance, but controlled human trials are lacking. Claims about human performance are not established by published evidence.

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

Network